Consensus in the Management of Multiple Myeloma in India at Myeloma State of the Art 2016 Conference
Pankaj Malhotra(Post Graduate Institute of Medical Education and Research), Shaji Kumar(Mayo Clinic in Arizona), Sundar Jagannath(Mount Sinai Medical Center), Uday Yanamandra(Army Hospital Research and Referral), Navin Khattry(Tata Memorial Hospital), Noopur Raje(Massachusetts General Hospital), Hari Menon(All India Institute of Medical Sciences), Lalit Kumar(GNA University), Arihant Jain(California University of Pennsylvania), Tapan Saikia(Prince Aly Khan Hospital), Neelam Varma(Nagpur Institute of Technology), Subhash Varma(Post Graduate Institute of Medical Education and Research)
Cited by 17
Related Papers
An inflammatory cytokine signature predicts COVID-19 severity and survival
|Nature Medicine|2020|2.7k
Revised International Staging System for Multiple Myeloma: A Report From International Myeloma Working Group
|Journal of Clinical Oncology|2015|2.2k
Anti-BCMA CAR T-Cell Therapy bb2121 in Relapsed or Refractory Multiple Myeloma
|New England Journal of Medicine|2019|1.7k
Vemurafenib in Multiple Nonmelanoma Cancers with <i>BRAF</i> V600 Mutations
|New England Journal of Medicine|2015|1.7k